<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">Cardiovascular disease</z:e> due to <z:hpo ids='HP_0002621'>atherosclerosis</z:hpo> is a leading cause of <z:hpo ids='HP_0011420'>death</z:hpo> around the world, including Singapore </plain></SENT>
<SENT sid="1" pm="."><plain>Current treatment strategies primarily target <z:chebi fb="2" ids="39026">low-density lipoprotein</z:chebi> (<z:chebi fb="15" ids="39026">LDL</z:chebi>) cholesterol levels </plain></SENT>
<SENT sid="2" pm="."><plain>Low levels of <z:chebi fb="6" ids="39025">high-density lipoprotein</z:chebi> (<z:chebi fb="17" ids="39025">HDL</z:chebi>) cholesterol and high <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (TG) levels have been shown to increase the risk of <z:e sem="disease" ids="C0010068" disease_type="Disease or Syndrome" abbrv="">coronary heart disease</z:e>, but the clinical benefits of raising <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo> have only been proven in a limited number of studies </plain></SENT>
<SENT sid="3" pm="."><plain>This guide provides an approach on managing <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo> levels in terms of lifestyle modifications and pharmacotherapy </plain></SENT>
</text></document>